Claims that the discovery of a gene could help prevent diabetes may raise unrealistic expectations

NewsGuard 100/100 Score

Claims that the discovery of a gene could help prevent diabetes may raise unrealistic expectations, warn doctors in this week's British Medical Journal.

Earlier this year, scientists discovered that a variant of the TCF7L2 gene was associated with type 2 diabetes. In subsequent media coverage, they claimed this could lead to a diagnostic test to identify people who carry the variant gene and that people who knew of their extra risk would then be motivated to avoid the lifestyle habits that lead to diabetes.

Undeniably this discovery is noteworthy, write Cecile Janssens and colleagues. Type 2 diabetes is a leading cause of illness and death in the developed world and is increasing in prevalence worldwide. The association is robust - the investigators replicated their finding in three large, independent study populations - and it offers potential new insight into the pathobiology of diabetes.

Yet the claim that this knowledge will lead to a diagnostic test and hence to disease prevention – now routine for such genetic discoveries – may not be true and, above all, misleads the public.

Even if this discovery led to a 100% effective intervention that specifically targeted the effects of the genetic variant, 45% of the general population would need to receive this intervention to prevent 21% of diabetes cases, they explain. An intervention that specifically targets the effects of TCF7L2 variants would therefore need to be cheap, harmless, and burdenless to warrant such substantial overtreatment.

Alternatively, the genetic test could identify people at high risk who would benefit from appropriate advice on diet and physical activity. But many carriers would find their risk increased from 33% to only 38%. Would these figures provide enough incentive for them to change their lifestyles, they ask?

Ultimately, genetic discoveries may lead to better understanding of the disease process and to better therapeutic and preventive interventions, say the authors. In the meantime, scientists and the media are responsible for accurately and carefully interpreting the implications of studies of genetic associations for the benefit of the general public.

"Raising unrealistic expectations – even inadvertently – could distract attention from what can be done by applying what we already know to prevent diabetes and its complications, they conclude.


Contact:
Cecile Janssens, Epidemiologist, Department of Public Health, Erasmus MC University Medical Centre, Rotterdam, Netherlands
Tel: +31 6 1661 4632
Email: [email protected]

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles